148 related articles for article (PubMed ID: 6605854)
1. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
2. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect].
Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053
[TBL] [Abstract][Full Text] [Related]
3. [The electrophysiologic effects of intravenously administered bepridil].
Ponsonnaille J; Citron B; Threil F; Heiligenstein D; Gras H
Arch Mal Coeur Vaiss; 1982 Dec; 75(12):1415-23. PubMed ID: 6820263
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
5. [Bepridil in the treatment of supraventricular paroxysmal tachycardias].
Medvedowsky JL; Barnay C; Arnaud C; Bonet P; Quittet F; Lam LF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():67-74. PubMed ID: 3938262
[TBL] [Abstract][Full Text] [Related]
6. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
[TBL] [Abstract][Full Text] [Related]
7. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
Singh BN; Nademanee K; Feld G; Piontek M; Schwab M
Am J Cardiol; 1985 Mar; 55(7):14C-19C. PubMed ID: 3872052
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of oral bepridil in ventricular arrhythmias in stable coronary insufficiency].
Rio A; Pasco A; Dupont T; Deroubaix G; Moulinie E; Rossignol B; Pellet J; Brechenmacher C
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():75-8. PubMed ID: 3938263
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic effects of bepridil on the human heart].
Valère PE; Belin A; Chentir T; Lehner JP; Guerot C; Tricot R
Ann Cardiol Angeiol (Paris); 1982; 31(5):409-15. PubMed ID: 6984315
[No Abstract] [Full Text] [Related]
11. [Bepridil and bundle of His block. Apropos of a case].
Marchand X; Zannier D; Pathé M; Baron B; Hotton JM; Kahn JC
Arch Mal Coeur Vaiss; 1988 Mar; 81(3):339-42. PubMed ID: 3134872
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
Bödeker K; Bischoff KO; Menken U; Hager W
Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiology of tiapamil in humans.
Lévy S; Burtey JP; Labrunie P; Faugère G; Valeix B; Cano JP; Gérard R
Cardiology; 1982; 69 Suppl():117-23. PubMed ID: 7151072
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of clinical efficacy and tolerance of bepridil in patients with effort-induced angina pectoris].
Lai C; Pirisi R; Onnis E; Tallu B; Delogu G; Cherchi A; Arca M; Cherchi A
Cardiologia; 1985 Jul; 30(7):527-31. PubMed ID: 3914919
[No Abstract] [Full Text] [Related]
15. Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist.
Vetrovec GW; Dailey S; Kay G; Epstein A; Plumb V
Postgrad Med J; 1991; 67 Suppl 5():S60-1. PubMed ID: 1839444
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic effects of a new calcium antagonist, bepridil, in patients with coronary artery disease].
Haerer VW; Stauch M
Arzneimittelforschung; 1987 Jul; 37(7):829-31. PubMed ID: 3499908
[TBL] [Abstract][Full Text] [Related]
17. The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
Lynch JJ; Montgomery DG; Lucchesi BR
J Pharmacol Exp Ther; 1986 Nov; 239(2):340-5. PubMed ID: 3490565
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride.
Upward JW; Daly K; Campbell S; Bergman G; Jewitt DE
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1589-95. PubMed ID: 3873868
[TBL] [Abstract][Full Text] [Related]
19. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
[TBL] [Abstract][Full Text] [Related]
20. [Effect of bepridil on the heart rate of the healthy subject. Correlation with plasma levels].
Kantelip JP; Duchène-Marullaz P; Trolèse JF; Pognat JF
Arch Mal Coeur Vaiss; 1983 Feb; 76(2):221-6. PubMed ID: 6407430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
